Howe & Rusling’s Taiwan Liposome Company, Ltd. American Depository Shares TLC Stock Holding History

Howe & Rusling’s Portfolio TLC Stock Details TLC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-500	Closed	-$2K	–	1025
2020 Q3	$2K	Hold	500	–	–	﹤0.01%	749
2020 Q2	$3K	Hold	500	–	–	﹤0.01%	650
2020 Q1	$2K	Hold	500	–	–	﹤0.01%	670
2019 Q4	$3K	Hold	500	–	–	﹤0.01%	648
2019 Q3	$3K	Hold	500	–	–	﹤0.01%	656
2019 Q2	$3K	Hold	500	–	–	﹤0.01%	639
2019 Q1	$3K	Buy	+500	New	+$3.08K	﹤0.01%	644

Other funds holding TLC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Howe & Rusling's TLC Position: Q4 2020 in Review

Howe & Rusling sold out of Taiwan Liposome Company, Ltd. American Depository Shares (TLC) in Q4 2020, closing a stake of 500 shares — an estimated $2K sold.

Howe & Rusling first reported a position in TLC in Q1 2019 and held it in 7 quarters. The position peaked at $3K in Q2 2020. 4 funds tracked by Wall St. Rank hold TLC as of Q4 2020.

Howe & Rusling reported no remaining Taiwan Liposome Company, Ltd. American Depository Shares position as of Q4 2020 after selling out during the quarter.
Howe & Rusling sold 500 Taiwan Liposome Company, Ltd. American Depository Shares shares in Q4 2020, an estimated $2K.
Howe & Rusling first reported a position in Taiwan Liposome Company, Ltd. American Depository Shares in Q1 2019 and held it in 7 quarters.
Howe & Rusling's Taiwan Liposome Company, Ltd. American Depository Shares position peaked at $3K in Q2 2020.
4 funds tracked by Wall St. Rank held Taiwan Liposome Company, Ltd. American Depository Shares as of Q4 2020.

Based on Howe & Rusling's 13F filing for Q4 2020, filed 8 Feb 2021.